Anish Nag

According to our database, Anish Nag authored at least 5 papers between 2021 and 2024.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of four.

2024

A top-down approach for studying the in-silico effect of the novel phytocompound tribulusamide B on the inhibition of Nipah virus transmission through targeting fusion glycoprotein and matrix protein.

Deblina Rababi, Anish Nag

Comput. Biol. Chem., 2024

2023

An <i>in-silico</i> pharmacophore-based molecular docking study to evaluate the inhibitory potentials of novel fungal triterpenoid Astrakurkurone analogues against a hypothetical mutated main protease of SARS-CoV-2 virus.

Anish Nag, Adhiraj Dasgupta, Sutirtha Sengupta, Tapan Kumar Lai, Krishnendu Acharya

Comput. Biol. Medicine, 2023

2022

Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an <i>in silico</i> study.

Anish Nag, Ritesh Banerjee, Subhabrata Paul, Rita Kundu

Comput. Biol. Medicine, 2022

2021

Network pharmacological evaluation for identifying novel drug-like molecules from ginger (Zingiber officinale Rosc.) against multiple disease targets, a computational biotechnology approach.

Anish Nag, Ritesh Banerjee

Netw. Model. Anal. Health Informatics Bioinform., 2021

<i>In silico</i> study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools.

Anish Nag, Subhabrata Paul, Ritesh Banerjee, Rita Kundu

Comput. Biol. Medicine, 2021